SCHEMBL21677836

SCHEMBL21677836

Nc1cc(O)c2cn[nH]c2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 2/20 0.41
▸ RET P07949 1/20 0.41
▸ PI4KA P42356 1/20 0.41
▸ LRRK2 Q5S007 1/20 0.41
▸ PI4K2B Q8TCG2 1/20 0.41
▸ PI4K2A Q9BTU6 1/20 0.41
▸ PI4KB Q9UBF8 1/20 0.41
▸ CHEK1 O14757 2/20 0.38
▸ GRK2 P25098 2/20 0.38
▸ ADORA2A P29274 2/20 0.36
▸ ADORA1 P30542 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ ROCK2 O75116 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31706376 0.80 CHEK1 (0.45) XDHRETPI4KALRRK2PI4K2B
SCHEMBL18012909 0.77 BACE1 (0.43) XDHRETPI4KALRRK2PI4K2B
SCHEMBL19966396 0.77 FGFR1 (0.39) XDHRETPI4KALRRK2PI4K2B
SCHEMBL19841348 0.73 SMN1; SMN2 (0.42) XDHRETPI4KALRRK2PI4K2B
SCHEMBL17998714 0.73 ALDH1A1 (0.39) XDHRETPI4KALRRK2PI4K2B
SCHEMBL888387 0.71 ADORA2A (0.47) XDHRETPI4KALRRK2PI4K2B
SCHEMBL95394 0.71 XDH (0.52) XDHRETPI4KALRRK2PI4K2B
Oxypurinol SCHEMBL49280 0.65 SMN1; SMN2 (0.38) XDHRETPI4KALRRK2PI4K2B
SCHEMBL29487078 0.65 XDH (0.55) XDHRETPI4KALRRK2PI4K2B
SCHEMBL1014920 0.65 XDH (0.55) XDHRETPI4KALRRK2PI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof MAPKAPK2, MAP4K2, MKNK2 XDH 4033/4885RET 524/4885PI4KA 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback